TTK Healthcare AGM 2026: ₹10 Dividend, Chairman Reappointed

What shareholders approved at the 68th AGM

TTK Healthcare Limited concluded its 68th Annual General Meeting (AGM) on July 26, 2026, with shareholders voting in favour of key proposals placed before them. The meeting cleared a final dividend of ₹10.00 per equity share, alongside routine and governance-related resolutions. Shareholders also approved the adoption of audited financial statements for the year ended March 31, 2026. Another major item was the reappointment of T T Raghunathan as Executive Chairman for a fresh term of five years. The AGM was held through video conferencing and other audio visual means (VC/OAVM), aligning with the framework permitted under applicable regulations. The company indicated that the AGM process included shareholder engagement and followed SEBI and Ministry of Corporate Affairs (MCA) guidelines. Voting was carried out through e-voting routes, with results derived by combining remote e-voting and votes cast during the AGM.

Virtual AGM format and compliance framework

The AGM was conducted through VC/OAVM, a format that has become common for listed companies operating under SEBI and MCA directions for electronic meetings. TTK Healthcare stated that shareholders participated and engaged during the virtual meeting. The company also described its voting approach as compliant with the relevant guidelines. Remote e-voting, coupled with voting during the AGM, was used to determine outcomes for the items of business. This structure is designed to allow participation for shareholders who vote ahead of time as well as those who choose to vote during the meeting window. The overall process, as described, was intended to ensure that resolutions are decided transparently through recorded electronic votes. The company also noted that the scrutinizer’s report and the final voting results were scheduled to be uploaded to its website within two working days of the AGM’s conclusion.

Dividend decision: ₹10 per share approved

One of the central outcomes of the 68th AGM was shareholder approval for a dividend of ₹10.00 per share, described as 100% on equity shares. The approval was passed as an ordinary resolution. For investors, the announcement is a key datapoint because it determines the cash payout per share approved by shareholders. Beyond the per-share figure, the AGM disclosure in the provided material did not specify record date or payment date for this dividend. The resolution, however, confirms the shareholders’ consent for the declared payout amount.

Executive Chairman reappointment for five years

Shareholders approved a special resolution to reappoint Mr T T Raghunathan (DIN: 00043455) as Executive Chairman. The term approved is for five years starting from November 01, 2026. Reappointments at the board and top executive level typically require shareholder approval, and in this case the company placed the matter as a special resolution. The AGM outcome confirms the continuity of leadership in the Executive Chairman role for the stated tenure. The provided AGM note did not include additional details on remuneration structure or performance-linked terms for the reappointment.

Financial statements adopted for FY ended March 31, 2026

The AGM also passed the ordinary resolution for adoption of the audited financial statements for the year ended March 31, 2026. Adoption of accounts is a routine annual item but remains a key corporate action since it formally places the audited numbers before shareholders for approval. The company’s disclosure in the provided text confirms the passing of this resolution. No specific profit, revenue, margin, or balance sheet figures were included in the supplied material, and hence the AGM outcome is limited to the fact of adoption.

Director appointment by rotation

Another ordinary resolution approved at the AGM was the appointment of Mr. Krishnamurthy Shankaran (DIN: 00043205) as a Director retiring by rotation. Such appointments are part of standard corporate governance processes where directors periodically retire and may offer themselves for reappointment. The AGM outcome confirms that shareholders supported the resolution placed for this director’s appointment.

Cost auditor remuneration ratified

Shareholders also approved the ratification of remuneration payable to M/s Geeyes & Co., Cost Auditors, for the financial year ending March 31, 2027. This was passed as an ordinary resolution. The AGM disclosure indicates that the board placed this item for shareholder ratification, and the proposal received approval. The provided material does not specify the quantum of the remuneration, only that the remuneration was ratified.

Summary of resolutions passed

The AGM included five items of business, approved through e-voting, with outcomes computed by combining remote e-voting and voting during the AGM.

Separate strategic update: EVA and Good Home brand sale to Wipro

Alongside the AGM outcomes, the provided material also references a separate corporate development: TTK Healthcare’s approval for the sale of its EVA and Good Home brands to Wipro Enterprises Private Limited. The consideration mentioned is ₹256 crore plus applicable GST. Definitive agreements for the transaction were signed on July 23, 2026. The transaction is expected to close by September 30, 2026, subject to customary conditions precedent, as stated in the supplied text.

Background on voting processes referenced in disclosures

The supplied material also contains references to earlier voting-related disclosures, including postal ballot processes and remote e-voting timelines. One such disclosure refers to a postal ballot process connected to the appointment of Mr V Sundaresan (DIN: 11435475) as an Independent Director for a term of five years with effect from December 22, 2025, with the scrutinizer’s report dated January 27, 2026. These references underline the broader framework listed companies use for shareholder approvals through electronic voting and scrutinizer verification. Separately, the material includes an agenda-wise voting table for a postal ballot item relating to voluntary delisting from BSE and NSE, dated May 22, 2023, along with category-wise voting break-up. Those voting tables are presented as part of the provided text but are not described as part of the July 26, 2026 AGM resolutions list.

Why this AGM matters for investors tracking TTK Healthcare

For shareholders, the AGM outcomes matter on two practical fronts. First, the approval of a ₹10 per share dividend sets a confirmed payout per share, subject to the company’s administrative process and timelines not detailed in the supplied note. Second, board and leadership continuity is reinforced through the reappointment of the Executive Chairman for a fixed five-year term commencing November 01, 2026. The adoption of FY26 audited accounts and approval of routine governance items like director appointment by rotation and cost auditor remuneration also complete the company’s annual compliance cycle. In parallel, the EVA and Good Home brand sale update adds a major corporate action with a stated consideration of ₹256 crore plus GST and an expected closing timeline by September 30, 2026, subject to conditions precedent.

Conclusion

TTK Healthcare’s 68th AGM on July 26, 2026 approved five resolutions, including a ₹10 per share dividend and the reappointment of T T Raghunathan as Executive Chairman for five years from November 01, 2026. The company said scrutinizer findings and final voting results would be uploaded on its website within two working days of the meeting’s conclusion. Separately, the company has disclosed definitive agreements signed on July 23, 2026 to sell the EVA and Good Home brands to Wipro Enterprises Private Limited for ₹256 crore plus applicable GST, with closing expected by September 30, 2026 subject to customary conditions precedent.